MCKMcKesson Corporation
Price
+36%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, price roughly fair, growth steady, the market undecided.
McKesson Corporation together with its subsidiaries (collectively, the “Company,” “McKesson,” “we,” “our,” or “us” and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.
In the company’s own words · 10-K filed May 8, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
McKesson Corporation (MCK) reported revenue of $105.4B in Q1 2027 (quarter ended Jun 30, 2026), up 7.7% from the same quarter a year earlier. That came with a gross margin of 3.5% and net income of $614M (0.6% of revenue). For the full year FY2026, revenue was $403.4B (+12% year on year) and net income $4.76B. Its largest segment in Q1 2027 was North American Pharmaceutical at $86.8B, 82% of the disclosed total, well ahead of Oncology And Multispecialty at 13%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 6, 2026CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health.Regulation FD disclosure · press release
- Aug 5, 2026IRVING, Texas, August 5, 2026 - McKesson Corporation (NYSE:MCK) today announced results for the first quarter ended June 30, 2026.Earnings release · press release
- Jul 1, 2026Departure of Certain Officers On June 29, 2026, Thomas L. Rodgers, the company’s Executive Vice President, Chief Strategy and Business Development Officer and a named executive officer, gave notice of his intention to retire from that role.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $105.38BThe company’s own SEC segment disclosure.
- North American Pharmaceutical$86.77B82%
- Oncology And Multispecialty$14.22B13%
- Medical Surgical Solutions$2.82B3%
- Prescription Technology Solutions$1.57B1%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Healthcare
Ranks #2 of 446 by RyuScore